OKUR – onkure therapeutics, inc. - class a (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

OKUR

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/16

08:03 am

okur

OnKure Therapeutics (OKUR) had its price target lowered by HC Wainwright from $34.00 to $27.00. They now have a "buy" rating on the stock.

Low Report

OnKure Therapeutics (OKUR) had its price target lowered by HC Wainwright from $34.00 to $27.00. They now have a "buy" rating on the stock.

Report

3/14

01:32 am

okur

OnKure Therapeutics (OKUR) was upgraded by Wall Street Zen from "sell

Low Report

OnKure Therapeutics (OKUR) was upgraded by Wall Street Zen from "sell

Report

3/12

04:05 pm

okur

OnKure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

Medium Report

OnKure Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.